Mcm2 expression is known to be downregulated when homozygous Mcm2-CreER mice (Mcm2CreER/CreER) are used, resulting in the loss of ASCs/PCs and the formation of cancer (likely because of genome instability) (Pruitt et al., 2007). This evidence concerns the gene MCM2 and cancer.